FORMATO, Marilena
 Distribuzione geografica
Continente #
NA - Nord America 3.965
EU - Europa 2.327
AS - Asia 1.467
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 18
SA - Sud America 8
AF - Africa 4
Totale 7.808
Nazione #
US - Stati Uniti d'America 3.940
UA - Ucraina 1.093
CN - Cina 1.078
DE - Germania 369
SG - Singapore 296
IT - Italia 286
FI - Finlandia 178
SE - Svezia 169
FR - Francia 78
GB - Regno Unito 76
KR - Corea 37
TR - Turchia 32
BE - Belgio 29
CA - Canada 23
AU - Australia 17
EU - Europa 17
BR - Brasile 8
DK - Danimarca 7
CZ - Repubblica Ceca 5
GR - Grecia 5
HR - Croazia 5
IN - India 5
JP - Giappone 5
IR - Iran 3
LU - Lussemburgo 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
IE - Irlanda 2
IL - Israele 2
MA - Marocco 2
NL - Olanda 2
NO - Norvegia 2
PL - Polonia 2
RU - Federazione Russa 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
VN - Vietnam 1
Totale 7.808
Città #
Chandler 1.028
Jacksonville 684
Princeton 356
Nanjing 294
Singapore 199
Dearborn 172
New York 166
Wilmington 147
Sassari 135
Nanchang 134
Ann Arbor 102
Boardman 98
Beijing 87
Shenyang 84
Hebei 71
Changsha 67
Tianjin 59
Jiaxing 46
Santa Clara 46
Woodbridge 45
Andover 39
Jinan 38
Seoul 37
Ashburn 36
Zhengzhou 35
Ningbo 34
Kunming 31
Mountain View 31
Brussels 29
Hangzhou 26
Izmir 26
Norwalk 24
San Francisco 22
Toronto 21
Taizhou 15
Cagliari 14
Guangzhou 14
Villiers-sur-marne 12
Helsinki 11
Changchun 10
Lanzhou 9
Hanover 8
Los Angeles 8
Dallas 7
Melbourne 7
Auburn Hills 6
Ficarazzi 6
Oristano 6
Augusta 5
Brno 5
London 5
San Mateo 5
Zagreb 5
Canberra 4
Leawood 4
Munich 4
Pátrai 4
Rome 4
Shanghai 4
Sydney 4
Tokyo 4
Verona 4
Ardabil 3
Edinburgh 3
Falls Church 3
Molfetta 3
Bangkok 2
Cedar Knolls 2
Dublin 2
Fairfield 2
Frankfurt am Main 2
Haikou 2
Hefei 2
Luxembourg 2
Monmouth Junction 2
Mumbai 2
Paris 2
Potenza 2
Qingdao 2
Romola 2
San Jose 2
Seattle 2
Senis 2
Serramanna 2
São Paulo 2
Tappahannock 2
Torino 2
Turin 2
Villanovaforru 2
Warsaw 2
Acquaviva Delle Fonti 1
Adelaide 1
Agadir 1
Almere Stad 1
Americo Brasiliense 1
Amsterdam 1
Atlanta 1
Baku 1
Belgrade 1
Berlin 1
Totale 4.713
Nome #
Assessment of protein-incorporated arginine methylation in biological specimens by CZE UV-detection 91
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 85
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 77
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 74
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 73
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 72
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 72
A study of the switch of fetal hemoglobin in newborn erythrocytes fractionated by density gradient 71
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 69
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 68
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 67
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 66
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 65
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 65
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 64
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 62
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 62
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 62
Distribution of low - density lipoprotein-bound low molecular weight thiols: a new analytical approach 62
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 60
Hemoglobin Hamilton [β11(A8)Val→Ile] in Sardinia 60
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 59
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 58
Biodiversità marina della Sardegna: prospettive di valorizzazione e sfruttamento sostenibile dei poriferi 58
Morfogenesi cronica dei poriferi: la strutturazione della matrice extracellulare è modulata dai glicosaminoglicani? 57
Diagnosi neonatale delle emoglobinopatie mediante isoelettrofocusing delle Emoglobine 57
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 55
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 55
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 55
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 54
A reversed phase HPLC method for the simultaneous determination of all monosaccharides contained in galactosaminoglycan isomers from human aorta proteoglycans 54
Lipoprotein(a) and the arterial wall 54
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 54
Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients. IF 2000: 2.071 JCR: Q1 53
Identification and characterization of biomarkers in atherosclerosis and diabetes. 53
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 53
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 53
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 52
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 52
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 52
Oxidative Modifications in Advanced Atherosclerotic Plaques: A Focus on In Situ Protein Sulfhydryl Group Oxidation 52
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 51
Urinary excretion of GAGs during hypocholesterolemic therapy 51
Structural analysis of glycosaminoglycans and proteoglycans from fresh porcine aortic valves 50
Structural determinants in the C-terminal domain of apolipoprotein E mediating binding to the protein core of human aortic biglycan. IF 2000: 7.368 JCR: Q1 49
Sequence variability of apolipoprotein E gene in Corsico-Sardinian ovines 49
Differential proteomic analysis of human atherosclerotic plaque extracts 49
Apolipoprotein Profiles in Atherosclerotic Disease 48
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 48
Evaluation of low molecular mass thiols content in carotid atherosclerotic plaques 47
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 47
Role of the small proteoglycan bikunin in human reproduction 47
Buoyant density of Lp(a) subclasses in hypercholesterolemia 47
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 47
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 47
Cryopreservation of porcine aortic valve: open status of the aortic leaflets results in increased matrix glycosaminoglycan structural maintenance 46
Cellular adhesion of rat hepatocytes during the last phase of the phenotype differentiation 46
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 46
Apolipoprotein profiles in atherosclerotic disease 46
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 46
Apolipoprotein Profiles in Atherosclerotic Disease 46
Protein oxidation in unstable plaque extracts from human carotid segments 45
GAG and protein composition of GAG-protein complexes from normal human plasma 45
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 45
Determination of galactosaminoglycan disaccharides by high performance capillary electrophoresis: applications to analysis of human aorta proteoglycans 45
Investigation on the interactions between LDL and proteoglycans from human aortas 45
Estrogen receptors in the liver of intact and gonadectomized rats: determination by hydroxylapatite assay 45
Atherosclerotic modifications of human proteoglycans 45
Adhesion properties and proteoglycans produced by subsequent subcultures of rat fibroblasts with different contact inhibition 45
Factors affecting S-homocysteinylation of LDL apoprotein B 45
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 45
Proteomic analysis of differential protein expression and post-translational modifications in human atherosclerotic plaques 44
Valorizzazione e sfruttamento sostenibile dei poriferi: la spongicoltura nella fascia costiera 44
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 44
LDL interactions with different aorta proteoglycans 44
Morfogenesi cronica dei poriferi: la struttura della matrice extracellulare è modulata dai glicosaminoglicani? 44
The role of GAGs in cell to cell adhesion of rat fibroblasts: a preliminary investigation 44
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 43
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 43
Serum Lp(a) levels in chronic haemodialysis patients 43
A study of the switch of fetal hemoglobin in newborn erytrocytes fractionated by density gradient. 43
The gamma globin chain heterogeneity of the Sardinian newborn baby. Hemoglobin, 10:519-528, 1986. 43
Generalized absence-like seizures induced by ketamine in the rat 43
IDENTIFICATION, QUANTIFICATION AND STRUCTURAL CHARACTERIZATION OF GLYCOSAMINOGLYCANS FROM PORCINE AORTIC VALVE TISSUE 43
Evidence for a pro-oxidant environment in atherosclerotic plaques from human carotid segments 42
CRYOPRESERVATION OF AORTIC VALVE:OPEN STATUS OF THE AORTIC LEAFLETS RESULTS IN INCREASED MATRIX GLYCOSAMINOGLYCAN MAINTENANCE 42
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 42
Modifications of low density lipoprotein induced by the interaction with heparin, chondroitin 6 sulphate and plasma high charge GAG-protein complexes 42
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 42
Apolipoprotein profiles in atherosclerotic disease 42
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 42
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 42
Cryopreservation of porcine aortic valve on open status increased matrix glycosaminoglycan structural maintenance 42
Modifications of adhesion properties and proteoglycan structure in rat embryo fibroblast cultures with increasing passages 42
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 42
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 41
Glycosaminoglycan biodiversity in W-Mediterranean marine sponges. 41
Post-translational modifications of proteoglycans during the development of atherosclerotic lesion 41
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 41
Preliminary investigations on LDL interactions with proteoglycans extracted from human aortic wall with different atherosclerotic lesions 41
Totale 5.172
Categoria #
all - tutte 39.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.091 0 0 0 15 180 152 283 19 190 48 202 2
2020/20211.249 176 7 206 7 174 38 176 4 200 197 43 21
2021/2022837 110 5 3 16 10 3 54 52 94 36 95 359
2022/20231.916 188 124 37 324 236 306 0 230 328 19 81 43
2023/2024594 93 41 15 16 133 102 6 32 9 12 76 59
2024/2025391 32 40 310 9 0 0 0 0 0 0 0 0
Totale 7.884